Kyuichi Kadota

Senior Research Scientist

Start Year

2009

End Year

2015

Awards and Scholarships

Kagawa University Visiting Research Scholarship

Publications

Manuscripts

Abstracts/Presentations

  • Lu S, Tan KS, Kadota K, Eguchi T, Bains S, Adusumilli P, Travis W. Spread Through Air Spaces (STAS) is an Independent Predictor of Recurrence in Lung Squamous Cell Carcinoma. 2016 United States & Canadian Academy of Pathology Annual Meeting. March 12-18, 2016; Seattle, WA.
  • Ujiie H, Eguchi T, Mayor M, Kadota K, Travis WD, Jones DR, Sadelain M, Adusumilli PS. Targetable Cancer-Associated Antigens for Immunotherapy in Malignant Pleural Mesothelioma (MPM) - Mesothelin, CA125 and WT-1. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Ujiie H, Morello A, Kadota K, Buitrago DH, Woo K, Jones DR, Travis WD, Sadelain M, Adusumilli PS. Mesothelin and MUC16 (CA125) Are Antigen-Targets for CAR T-Cell Therapy in Primary and Metastatic Lung Adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Rizk NP, Woo KM, Sima CS, Park BJ, Jones DR, Travis WD, Adusumilli PS. T1a Lung Adenocarcinomas: Presence of Spread of Tumor through Alveolar Spaces (STAS), Micropapillary and Solid Patterns Determines Outcomes International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Buitrago DH, Mayor M, Kadota K, Rizk NP, Park BJ, Jones DR, Adusumilli PS. Long and Short-Term Predictors of Outcome in Elderly Patients (≥ 75 Years) Undergoing Lobectomy for Stage I Non-Small Cell Lung Cancer. International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Leduc C, Rekhtman N, Moreira A, Jones DR, Adusumilli PS. HNF4α Is a Marker for Invasive Mucinous Adenocarcinoma (IMA) and a Prognostic Factor in Stage I Lung Adenocarcinoma (LADC). International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Eguchi T, Kadota K, Leduc C, Rekhtman N, Moreira A, Jones DR, Adusumilli PS. HNF4α Is a Marker for Invasive Mucinous Adenocarcinoma (IMA) and a Prognostic Factor in Stage I Lung Adenocarcinoma (LADC). International Association for the Study of Lung Cancer (IASLC) 16th World Conference on Lung Cancer. September 6-9, 2015; Denver, CO.
  • Kadota K, Rekhtman N, Moreira AL, Arcila ME, Rusch VW, Adusumilli PS, Travis WD. Micropapillary Pattern and Invasive Tumor Size Are Prognostic Factors in Invasive Mucinous Adenocarcinoma of the Lung. United States & Canadian Academy of Pathology’s 103rd Annual Meeting, March 1-7, 2014, San Diego, CA.
  • Kadota K, Arcila ME, Cyrus Hedvat, Kris MG, Rusch VW, Adusumilli PS, Travis WD. Poor prognostic driver mutations in early stage lung adenocarcinomas (LADs): BRAF and KRAS mutations for all LADs and KRAS mutations within the solid subtype alone. United States & Canadian Academy of Pathology’s 103rd Annual Meeting. March 1-7, 2014; San Diego, CA.
  • Ujiie H, Buitrago D, Nitadori J, Kadota K, Krug L, Travis WD, Rusch VW, Sadelain M, Adusumilli PS. CD8 T-cell infiltration and tumor IL-7R expression are independent prognostic factors in epithelioid malignant pleural mesothelioma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Yeh YC, Nitadori J, Kadota K, Yoshizawa A, Rekhtman N,   Moreira A, Sima CS, Rusch VW, Adusumilli PS, Travis WD. Accuracy and interobserver agreement in identifying histologic subtypes in stage I lung adenocarcinoma ≤ 3 cm using frozen section. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013. Sydney, Australia.
  • Kadota K, Nitadori J, Finley D, Rusch VW, Adusumilli PS, Travis WD. Tumor budding and nuclear grade but not histologic subtyping are significant prognostic factors independent of TNM stage in patients with lung squamous cell carcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Ujiie H, Buitrago D, Kadota K, Huang J, Travis WD, Rusch VW, Adusumilli PS, Rizk NP. Sites, symptoms, CT scan findings and survival in patients with recurrence after curative-intent surgical resection for stage I lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Kadota K, Nitadori J, Rusch VW, Rekhtman N, Sarkaria IS, Adusumilli PS, Travis WD. Reclassification of resected non-small cell lung carcinomas originally diagnosed as squamous cell carcinoma after reevaluation using immunohistochemistry (p40, p63, TTF-1, and Napsin A): Memorial Sloan-Kettering Cancer Center Experience. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Kadota K, Yeh YC, Rizk NP, Rusch VW, Adusumilli PS, Travis WD. Tumor budding is a significant prognostic factor for recurrence independent of IASLC/ATS/ERS classification in patients with stage I lung adenocarcinoma, and correlates with protumor immune microenvironment. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Kadota K, Nitadori J, Cherkassky L, Rusch VW,  Travis WD, Sadelain M, Adusumilli PS. Prognostic impact of tumor-infiltrating immune cells in lung squamous cell carcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Lee MC, Kadota K, Ujiie H, Travis WD, Rusch VW, Sadelain M, Adusumilli PS. The Tumor immune microenvironment in octogenarians with stage I non-small cell lung cancer: Implications for immunotherapy. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Buitrago D, Kadota K, Rusch VW, Patnaik S, Adusumilli PS. MicroRNA profiling analysis in resectable formalin-fixed paraffin-embedded non small cell lung cancer specimens by microarray and next generation sequencing. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Villena-Vargas J, Kadota K, Nitadori J, Sima CS, Krug L, Travis WD, Rusch VW, Adusumilli PS. CD10 expression is an independent prognostic factor among all histological types of malignant pleural mesothelioma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Chen YC, Nitadori J, Kadota K, Sima CS, Rizk NP, Rusch VW, Travis WD, Adusumilli PS. Micropapillary histological subtyping is associated with occult lymph node metastasis (pN2) in clinically N2 negative (cN0/N1) stage I lung adenocarcinoma patients. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Nitadori J, Kadota K, Sima CS, Ujiie H, Rizk NP, Rusch VW, Travis WD, Adusumilli PS. Spread through alveolar spaces (STAS): A newly recognized pattern of invasion in lung adenocarcinoma associated with increased recurrence in patients undergoing limited resection for ≤2cm tumors. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Sima CS, Kadota K, Rusch VW, Travis WD, Adusumilli PS. Prognostic value and implications in reporting overall survival and incidence of recurrence in stage I lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Kadota K, Cherkassky L, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Nuclear estrogen receptor-α expression is a significant prognostic factor for recurrence, independent from the IASLC/ATS/ERS classification, in patients with pathologic stage T1aN0M0 disease, and correlates with poor prognostic immune microenvironment in lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.
  • Lee MC, Buitrago D, Kadota K, Sima CS, Rusch VW, Travis WD, Sadelain M, Adusumilli PS. Incremental association of solid histological subtype with predominant immunoinhibitory microenvironment in stage I lung adenocarcinoma (Tumor IL-7R and stromal FoxP3). International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.  
  • Bograd A, Kadota K, Lee MC, Sarkaria IS, Rusch VW, Travis WD, Adusumilli PS. Tumoral neutral endopeptidase (CD10) expression predicts risk of recurrence, and further stratify intermediate-grade histology patients in stage I lung adenocarcinoma. International Association for the Study of Lung Cancer (IASLC) 15th World Conference on Lung Cancer. October 27-30, 2013; Sydney, Australia.